CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,874 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,060 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 3,314 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 5,150 shares (to pay taxes)
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,000 shares at $60.86 ($60,860)
- 4 Open-market sale SVP, GENERICS sold 5,384 shares at an average $60.00 ($323,049)
- 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 627 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,275 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 12,216 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 1,570 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 1,099 shares (to pay taxes)
- 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 1,099 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 1,861 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,000 shares at $60.20 ($60,200)
- 4 Grant or award HEAD OF R&D, COO-NOVITIUM OPS acquired 23,936 shares (grant or award)
Page 11 of 90 · 1,784 filings